Technical Analysis for ALMS - Alumis Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | N/A |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -2.43% | |
| Hot IPO Pullback | Bullish Swing Setup | -2.43% | |
| New 52 Week Low | Weakness | -2.43% | |
| Gapped Down | Weakness | -2.43% | |
| New 52 Week Closing Low | Bearish | -7.10% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 7 hours ago |
| Fell Below Previous Day's Low | about 7 hours ago |
| Down 2 % | about 7 hours ago |
| Up 1% | about 10 hours ago |
| Gap Up Closed | about 10 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.
Keywords: Autoimmune Disease Drug Development Autoimmunity Syndromes Personalized Medicine Sjögren Syndrome
Classification
Keywords: Autoimmune Disease Drug Development Autoimmunity Syndromes Personalized Medicine Sjögren Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.53 |
| 52 Week Low | 11.65 |
| Average Volume | 256,741 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 0.00 |
| Average True Range | 0.00 |
| RSI (14) | 0.00 |
| ADX | 0.0 |
| +DI | 0.00 |
| -DI | 0.00 |
| Chandelier Exit (Long, 3 ATRs) | N/A |
| Chandelier Exit (Short, 3 ATRs) | N/A |
| Upper Bollinger Bands | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 12.33 | ||||
| Resistance 3 (R3) | 12.41 | 12.26 | 12.22 | ||
| Resistance 2 (R2) | 12.26 | 12.08 | 12.22 | 12.18 | |
| Resistance 1 (R1) | 11.95 | 11.98 | 11.88 | 11.88 | 12.14 |
| Pivot Point | 11.80 | 11.80 | 11.76 | 11.76 | 11.80 |
| Support 1 (S1) | 11.50 | 11.63 | 11.42 | 11.42 | 11.16 |
| Support 2 (S2) | 11.35 | 11.52 | 11.31 | 11.12 | |
| Support 3 (S3) | 11.04 | 11.35 | 11.08 | ||
| Support 4 (S4) | 10.97 |
